Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Procaps Group, S.A. - Ordinary Shares (NQ:PROC)

1.010 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Procaps Group, S.A. - Ordinary Shares

< Previous 1 2 3 Next >
Keep an eye on the top gainers and losers in Monday's session.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Traders are paying attention to the gapping stocks in Monday's session.
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
Procaps Group Receives Delisting Notice From Nasdaq
From Procaps Group, S.A.
Via GlobeNewswire
Procaps Group Receives Additional Delinquency Letter
From Procaps Group, S.A.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates
From Procaps Group, S.A.
Via GlobeNewswire
Procaps Group Announces Financing, Shareholders Agreement and Board Updates
From Procaps Group, S.A.
Via GlobeNewswire
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing
From Procaps Group, S.A.
Via GlobeNewswire
Procaps Issues Shareholder Letter Update
From Procaps Group, S.A.
Via GlobeNewswire
Procaps Issues Shareholder Letter Update
From Procaps Group, S.A.
Via GlobeNewswire
Procaps Issues Shareholder Letter
From Procaps Group, S.A.
Via GlobeNewswire
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive. 
Via InvestorPlace
Procaps Group Announces New Chairman
From Procaps Group, S.A.
Via Business Wire
Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F
From Procaps Group, S.A.
Via Business Wire
Procaps Group Delays Filing of Annual Report on Form 20-F
From Procaps Group, S.A.
Via Business Wire
Procaps Group Delays Filing of Annual Report on Form 20-F
From Procaps Group, S.A.
Via Business Wire
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
5 Value Stocks In The Healthcare Sector
 
Via Benzinga
Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives
From Procaps Group, S.A.
Via Business Wire
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday. 
Via Benzinga
Topics Stocks
5 Value Stocks To Watch In The Healthcare Sector
 
Via Benzinga
Procaps Issues Shareholder Letter from New CEO
From Procaps Group
Via Business Wire
Procaps Group – Notice to Shareholders
From Procaps Group, S.A.
Via Business Wire
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
Pharma Company Procaps Beats On Q3 But Lowers FY23 Guidance: Here's Why
Procaps Group SA (NASDAQ: PROC) reported Q3 FY23 revenue of $118.41 million, beating the consensus of $110.4 million and rose 7% Y/Y (+2% Y/Y in constant currency), led by the performance of RX and OTC... 
Via Benzinga
Coherus BioSciences, Ascent Industries And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
PROC Stock Earnings: Procaps Gr Beats EPS, Beats Revenue for Q3 2023
PROC stock results show that Procaps Gr beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.